Urine excretion of nucleosides in Hodgkin's disease treated by combined chemotherapy.
The authors have followed the excretion of pyrimidine doexyribonucleosides in the urine of patients with generalized stages of Hodgkin's disease.  They proved an increased excretion of deoxyuridine and thymidine in these patients compared to healthy persons.  In the course of 14-days of combined chemotherapy a statistically significant increase in the excretion of DNA catabolites followed was found.
D003520:Cyclophosphamide / Q000627:therapeutic use; D003841:Deoxycytidine / Q000652:urine; D003853:Deoxyribonucleosides / Q000652:urine*; D003857:Deoxyuridine / Q000652:urine; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000188:drug therapy / Q000652:urine*; D006801:Humans; D011239:Prednisolone / Q000627:therapeutic use; D013936:Thymidine / Q000652:urine; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use
D003853:Deoxyribonucleosides; D003841:Deoxycytidine; D014747:Vinblastine; D003520:Cyclophosphamide; D011239:Prednisolone; D013936:Thymidine; D003857:Deoxyuridine